ChronicleBio
Decode. Define. Deliver.
Menlo Park, United States · $5.4M raised
- Headquarters
- Menlo Park, California
- Employees
- 11–50
- Business Model
- B2B
- Website
- chroniclebio.com
- Total Funding
- $5.4M
- Last Round
- $5.4M Venture RoundJul 2026
- Rounds
- 2
About
ChronicleBio is building the 'Internet of Biology' — a living data ecosystem that combines deep longitudinal patient data with AI to accelerate drug discovery and precision medicine for complex chronic diseases such as POTS and other neuroimmune conditions. Founded by Rohit Gupta (CEO), Fidji Simo (Director), and Rishi Reddy (Executive Chair), the company aims to eliminate the $5 trillion burden borne by patients with complex chronic diseases by powering AI-driven therapies and commercial breakthroughs at scale. ChronicleBio is headquartered in Menlo Park, California.
Summary
ChronicleBio is an Artificial Intelligence company based in Menlo Park, United States. It has raised $5.4M in total across 2 rounds, most recently a $5.4M Venture Round round in Jul 2026. Investors include Electric Capital, Tarsadia Capital and Wisdom Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company